Microsporidia Exam
Use
Microsporidia infection was first recognized as a cause of chronic diarrhea in patients infected with HIV. Microsporidia may also cause pneumonia, acute bilateral keratoconjunctivitis, and infection of the biliary and pancreatic ducts. ([jdos.nicholsinstitute.com](https://jdos.nicholsinstitute.com/dos/Medfusion/test/690829?utm_source=openai))
Special Instructions
Not provided.
Limitations
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. ([jdos.nicholsinstitute.com](https://jdos.nicholsinstitute.com/dos/Medfusion/test/690829?utm_source=openai))
New York Approved
Methodology
Other
Biomarkers
Microsporidia spores
Other
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Stool
Volume
5 grams
Minimum Volume
2 grams
Container
10% formalin or Total-Fix transport vial
Causes for Rejection
Unpreserved stool; stool in Cary‑Blair or PVA; received frozen
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 30 days |
| Refrigerated | 30 days |
| Frozen | Unacceptable |
Other tests from different labs that may be relevant